The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
Authors
Keywords
-
Journal
Lipids in Health and Disease
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-17
DOI
10.1186/s12944-020-1198-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
- (2018) ShadiSadat Seyyedebrahimi et al. ACTA DIABETOLOGICA
- Natural approaches in metabolic syndrome management
- (2018) Angelo Maria Patti et al. Archives of Medical Science
- Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial
- (2018) Konstantinos Kantartzis et al. DIABETES OBESITY & METABOLISM
- Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population
- (2018) Shou-Wu Lee et al. Hepatobiliary & Pancreatic Diseases International
- The Role of Nutraceuticals in Statin Intolerant Patients
- (2018) Maciej Banach et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind placebo-controlled trial
- (2018) Luis E. Simental-Mendía et al. NUTRITION
- Resveratrol supplementation decreases blood glucose without changing the circulating CD14 + CD16 + monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
- (2018) Hadi Khodabandehloo et al. NUTRITION RESEARCH
- Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke
- (2018) Katalin Fodor et al. Oxidative Medicine and Cellular Longevity
- The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk
- (2018) Alberto Mazza et al. Food & Function
- Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes
- (2018) Marlies de Ligt et al. Molecular Metabolism
- The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans
- (2018) Jasper Most et al. Adipocyte
- The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials
- (2018) Reza Tabrizi et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials
- (2018) Mohammad Vahid Jorat et al. Lipids in Health and Disease
- Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus
- (2017) Haruki Imamura et al. International Heart Journal
- No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
- (2017) Thomas Nordstrøm Kjær et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- Functional foods and dietary supplements for the management of dyslipidaemia
- (2017) Paola M. Hunter et al. Nature Reviews Endocrinology
- Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial
- (2016) Jasper Most et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Lipid-modifying effects of nutraceuticals: An evidence-based approach
- (2016) Amirhossein Sahebkar et al. NUTRITION
- Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: A randomized controlled trial
- (2016) María Angélica Arzola-Paniagua et al. Obesity
- The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
- (2016) Ahmad Zare Javid et al. PHYTOTHERAPY RESEARCH
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects
- (2016) Arrigo Cicero et al. Therapeutics and Clinical Risk Management
- Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
- (2016) Chongyang Zhang et al. PLoS One
- The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- (2015) Forouzan Faghihzadeh et al. BRITISH JOURNAL OF NUTRITION
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects
- (2015) S Biesinger et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials
- (2015) Amirhossein Sahebkar et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
- (2015) Sanne M. van der Made et al. PLoS One
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Effects of Resveratrol in Patients with Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure
- (2014) Kian Peng Goh et al. INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
- Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults
- (2014) A. V. Witte et al. JOURNAL OF NEUROSCIENCE
- Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
- (2014) Miriam Méndez-del Villar et al. Metabolic Syndrome and Related Disorders
- Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis
- (2014) Heather A. Hausenblas et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Effects of resveratrol and other polyphenols in hepatic steatosis
- (2014) Leixuri Aguirre WORLD JOURNAL OF GASTROENTEROLOGY
- Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
- (2013) Ali Movahed et al. Evidence-based Complementary and Alternative Medicine
- Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials
- (2013) Amirhossein Sahebkar NUTRITION REVIEWS
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life
- (2012) Constantin Militaru et al. NUTRITION
- Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
- (2012) Jayesh Kumar Bhatt et al. NUTRITION RESEARCH
- Hyperlipidemia as a Risk Factor for Cardiovascular Disease
- (2012) Robert H. Nelson PRIMARY CARE
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease
- (2011) Mangesh R. Pagadala et al. DIGESTIVE DISEASES AND SCIENCES
- High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
- (2011) V. W.-S. Wong et al. GUT
- Closer association of mitochondria with lipid droplets in hepatocytes and activation of Kupffer cells in resveratrol-treated senescence-accelerated mice
- (2011) Motoko Shiozaki et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment
- (2011) Keisuke Fujitaka et al. NUTRITION RESEARCH
- Resveratrol Improves Endothelial Function
- (2009) Hanrui Zhang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started